BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine

BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine

<i>Background:</i> Intra-vesical instillation of <i>Bacille Calmette&#8722;Gu&#233;rin</i> (BCG), an attenuated strain of <i>Mycobacterium bovis</i>, is an effective therapy for high-grade non-muscle invasive bladder cancer (NMIBC), which provokes a local...

Full description

Bibliographic Details
Main Authors: Omodele Ashiru, Gloria Esteso, Eva M. García‐Cuesta, Eva Castellano, Celia Samba, Eva Escudero-López, Sheila López‐Cobo, Mario Álvarez-Maestro, Ana Linares, Mei M. Ho, Asier Leibar, Luis Martínez‐Piñeiro, Mar Valés‐Gómez
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
cytokines
chemokines
NMIBC
BCG
biomarker
Online Access:https://www.mdpi.com/2072-6694/11/7/940

Internet

https://www.mdpi.com/2072-6694/11/7/940

Similar Items